Low T3 vs low T3T4 euthyroid sick syndrome in septic shock patients: A prospective observational cohort study
Authors:
Open Access
- 9 September 2024
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 13 (3) , 96132
Abstract
BACKGROUND Both phases of euthyroid sick syndrome (ESS) are associated with worse prognosis in septic shock patients. Although there are still no indications for supplementation therapy, there is no evidence that both phases (initial and prolonged) are adaptive or that only prolonged is maladaptive and requires supplementation. AIM To analyze clinical, hemodynamic and laboratory differences in two groups of septic shock patients with ESS. METHODS A total of 47 septic shock patients with ESS were divided according to values of their thyroid hormones into low T3 and low T3T4 groups. The analysis included demographic data, mortality scores, intensive care unit stay, mechanical ventilation length and 28-day survival and laboratory with hemodynamics. RESULTS The Simplified Acute Physiology Score II score (P = 0.029), dobutamine (P = 0.003) and epinephrine requirement (P = 0.000) and the incidence of renal failure and multiple organ failure (MOF) (P = 0.000) were significantly higher for the low T3T4. Hypoalbuminemia (P = 0.047), neutrophilia (P = 0.038), lymphopenia (P = 0.013) and lactatemia (P = 0.013) were more pronounced on T2 for the low T3T4 group compared to the low T3 group. Diastolic blood pressure at T0 (P = 0.017) and T1 (P = 0.007), as well as mean arterial pressure at T0 (P = 0.037) and T2 (P = 0.033) was higher for the low T3 group. CONCLUSION The low T3T4 population is associated with higher frequency of renal insufficiency and MOF, with worse laboratory and hemodynamic parameters. These findings suggest potentially maladaptive changes in the chronic phase of septic shock.Keywords
This publication has 28 references indexed in Scilit:
- Triiodothyronine hormone supplementation therapy in septic shock patients with euthyroid sick syndrome: two pilot, placebo-controlled, randomized trialsAnaesthesia Critical Care & Pain Medicine, 2023
- Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021Intensive Care Medicine, 2021
- An update on non-thyroidal illness syndromeJournal of Endocrinological Investigation, 2020
- Euthyroid sick syndrome in hip fractures: Valuation of vitamin D and parathyroid hormone axisInjury, 2020
- The Value of Decreased Thyroid Hormone for Predicting Mortality in Adult Septic Patients: A Systematic Review and Meta-AnalysisScientific Reports, 2018
- Impairment of Thyroid Function in Critically Ill Patients in the Intensive Care UnitsThe American Journal of the Medical Sciences, 2018
- Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious DiseasesMedicine, 2016
- Non-Thyroidal Illness in the ICU: A Syndrome with Different FacesThyroid®, 2014
- Efficacy of Perioperative Oral Triiodothyronine Replacement Therapy in Patients Undergoing Off-Pump Coronary Artery Bypass GraftingJournal of Cardiothoracic and Vascular Anesthesia, 2013
- Thyronin Treatment in Adult and Pediatric Heart Surgery: Clinical Experience and Review of the LiteratureEuropean Journal of Heart Failure, 2002